A review of orphan drugs and rare diseases
Journal Title: International Journal of Research in Pharmacology & Pharmacotherapeutics (IJRPP) - Year 2016, Vol 5, Issue 2
Abstract
The World Health Organization defines orphan diseases, as all pathological conditions, affecting 0.65-1 out of every 1000 inhabitants. They are usually not studied for their path physiology or for newer therapeutic options, as these are not economically viable. The Orphan Drug Act was passed on January 28, 1983 by USA to stimulate the research, development, and approval of those products that treat orphan diseases. Till date, 11 drugs (4.87%) for tropical infectious diseases has been designated with orphan drug status, and as many drugs for other infectious diseases. Several drugs with orphan status are used in the treatment of diseases that no longer meet orphan status criteria, such as AIDS and end-stage renal disease. Understanding of the human genome, nuclear cloning, rational drug designing, and application of high throughput screening in drug discovery programs, might lead to new drug discoveries for orphan diseases. Hence, there is hope in the future for patients neglected by for-profit drug discovery efforts.
Authors and Affiliations
Venkat Paluri
Keywords
Related Articles
- EP ID EP408374
- DOI -
- Views 119
- Downloads 0
A questionnaire based survey on antibiotic usage and resistance among second professional medical students in a tertiary care centre
BACKGROUND Antibiotics are among the most commonly prescribed medications which serve a very useful therapeutic purpose in eradicating pathogens; however they are very often misused. Health science students who are futu...
Computational and molecular designing studies of novel flavonoid analogues as HMG CoA Reductase and cholesterol esterase inhibitors for their Cardioprotective effect using in Silico docking studies
The objective of the study was to generate a series of pharmacophores from a parent flavone skeleton and evaluate their in silico HMG CoA reductase and cholesterol esterase enzyme inhibitory potential using the software...
Prescribing pattern of drugs in SNCU at a tertiary care hospital in South India
BACKGROUND SNCU (Sick New Born Care Unit) is meant to reduce the case fatality among sick newborns, either born within the hospital or outside including home delivery. The study of prescribing pattern is a part of the m...
An analytic comparative study about the antimicrobial activity of different generic and branded Amikacin on Escherichia coli - an In-vitro study
A Generic drug is a pharmaceutical product usually intended to be interchangeable with an innovator product that is manufactured without any license from the innovator company and marketed after the expiry date of the pa...
Brief overview on pathogenesis and treatment of diabetic nephropathy
Diabetic nephropathy is a serious condition affecting the patients worldwide suffering from diabetes mellitus. Diabetic nephropathy is the leading cause of Chronic Kidney Disease (CKD) in diabetic patients. About 25–40%...